fbpx

Search results

Author: InVivo Biosystems

Alzheimer’s and Epilepsy Panels
News & Announcements

New product releases from NemaMetrix

As a young and growing company, we are trying to design and introduce new products that can better serve your research needs. We’d like to share what we are working on. Sign up for notification and win a cool t-shirt.

Read More »
News & Announcements

NemaMetrix Introduces Fluorescent Staining Kits for Improved Phenotyping in model organism C. elegans

NemaMetrix, a company developing nematode-based drug development and screening technologies, announced the launch of its first series of RediStain™ fluorescent kits for improved visualization of C. elegans’ structure and function in phenotyping studies. These kits expand the toolkit of C. elegans research to include the ability to perform structural and functional assays that are standard in cell biology.

Read More »
Disease Modeling

New phenotype discovered for NPC disease using C. elegans

We discovered that in the absence of cholesterol, NPC mutants display a lower pharyngeal pumping frequency and a longer duration between pumps than control N2 animals. This is the progress we made in our collaborative research project with Perlara and investigation into the lysosomal disorder, Niemann-Pick Type C (NPC).

Read More »
Enlarge C. elegans Models | InVivo Biosystems
Drug Discovery

Are worms the future of drug development?

NemaMetrix’s ScreenChip collects live-animal, high-throughput C. elegans electropharyngeograms (EPGs), which are an indication of overall organism health for drug development. Read the blog post on BioCoder

Read More »
News & Announcements

ScreenChip Platform Recognized by the White House

The NemaMetrix ScreenChip platform technology was recognized by the White House as one of the breakthrough life science research technologies. CEO Matt Beaudet spoke with Dr. Robbie Barbero of the US White House Office of Science and Technology Policy, who created a post on the White House website about the promise of new research technologies.

Read More »
ONAMI logo - Oregon nanoscience and Microtechnologies Institute
News & Announcements

NemaMetrix announces GAP funding

  NemaMetrix announces being awarded $249,000 in GAP funding from Oregon Nanoscience and Microtechnologies Institute (ONAMI) to fund “proof-of-concept” work and to fuel development towards

Read More »
National Institutes of Health
News & Announcements

NemaMetrix Announces NIH funding

NemaMetrix announces being awarded $188,000 for a Phase I Small Business Innovation Research (SBIR) grant from the National Institute of Health. The funds will be used to support fundamental proof of concept research, with an eye towards near-term commercialization, of a microfluidic screening device for health-span extending drugs.

Read More »